FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
about
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activationCurrent strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen speciesEnhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplantsThe role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinomaActivation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.Ischemia-reperfusion injury in strokeCharacterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart.Identification of liver proteins and their roles associated with carbon tetrachloride-induced hepatotoxicity.FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cellsSphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation.The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants.Current perspectives on FTY720.Ischemia-reperfusion and immediate T cell responsesSphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis.Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injuryFingolimod provides long-term protection in rodent models of cerebral ischemia.Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.A sphingosine-1 phosphate agonist (FTY720) limits trauma/hemorrhagic shock-induced multiple organ dysfunction syndrome.Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants.FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1.Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kSphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation.
P2860
Q24309608-6357C80C-39F2-474E-A1C2-93AB445CB3F9Q26849214-4E485E0A-E81A-40EF-A38F-F9DF03CB4645Q27343108-8CFDAD55-369F-49F5-99A0-13A2B1D8D9B6Q28477884-4E73B451-98FF-44D9-A02C-C2DE190EFFD5Q30432124-90BDC542-9F8F-47F8-85EA-66849DDE1274Q30439331-1E9E1798-AF48-4AB6-91DE-9D915BA38D8FQ30884854-4FBE7D15-4527-4D9F-9013-1115368B36FEQ33653045-8351BE69-DC8F-4449-8859-B3602F94422AQ33720344-FBC010F3-CB91-4012-A284-149A7E22B8F6Q33765395-438AE19E-71F5-4ACB-BB70-2EB4096F9BE3Q34182635-6271D9D3-03CB-458C-85E7-C82777F8B7F7Q34430282-A737D363-1444-4835-B879-49C4C407C901Q36072077-A908AAE9-3040-4800-B6E3-70516C00F9EBQ36652104-40D6DC56-F891-4178-A3CF-BCAD067CB414Q36764024-DF36979D-1872-4D61-9463-3DED9074452CQ36973884-87B8CB69-7550-422C-BEB1-6123992092F1Q37675523-55167B84-6F01-42E4-AC2B-0AF04C5D12C5Q38123960-F573E6BC-368B-4A5B-80C2-EA10C1E838CBQ38806688-6C22B85B-8C70-4950-88CA-0C1BD171DAC5Q40075805-526B6346-737A-4DCE-B488-C9FD0928B9DCQ41836874-84ADB1C8-074D-4AD0-8E42-7112F699D70CQ42142782-24CF81FB-F481-4C4F-8F5B-BDF7634EF3D3Q42221398-F3D1BF28-6B8C-4B85-A2C8-67EFB9254E19Q44916450-79B16853-A566-459C-954B-988BCD03E9F5Q46837653-7F117097-DF6D-40CD-9576-81C005317E56Q47300876-0E5EF19B-6DB6-4788-9CCE-D0DC71B9EB83Q53563061-58DA3B33-5402-43C3-A9BB-2738BCFABC15
P2860
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@en
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@nl
type
label
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@en
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@nl
prefLabel
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@en
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
@nl
P2093
P2860
P1476
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers
@en
P2093
Chris K Sun
Chung Mau Lo
Joanna W Ho
Sheung Tat Fan
Xian Liang Li
P2860
P356
10.1111/J.1600-6143.2004.00642.X
P407
P577
2005-01-01T00:00:00Z